Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Thomas Jeffrey HargrovesDirector | CingulateCING | Open-market buy | 02/13 | 06/08 | 97,276 sh | $5.04 | $490,271.04 | +50664.6% |
CingulateCING | Open-market buy | 02/06 | 02/10 | 6,809 sh | $5.04 | $34,317.36 | +202.3% | |
Peter J. WerthDirector | CingulateCING | Open-market buy | 02/06 | 02/10 | 19,455 sh | $5.04 | $98,053.2 | +19.9% |
Jennifer L. CallahanSVP and CFO | CingulateCING | Open-market buy | 02/06 | 02/10 | 4,864 sh | $5.04 | $24,514.56 | +2494.4% |
Matthew BramsEVP and Chief Medical Officer | CingulateCING | Open-market buy | 02/06 | 02/10 | 1,946 sh | $5.04 | $9,807.84 | +71.8% |
Laurie MyersEVP and COO | CingulateCING | Open-market sale | 24/08/15 | 24/08/19 | 202 sh | $4.17 | $842.34 | −100.0% |
Jennifer L. CallahanSVP and CFO | CingulateCING | Open-market buy | 22/03/15 | 24/03/22 | 55 sh | $27.10 | $1,490.5 | +2.4% |
Jennifer L. CallahanCorporate Controller | CingulateCING | Open-market buy | 23/09/15 | 23/09/18 | 5,000 sh | $0.67 | $3,350 | +12.3% |
Peter J. WerthDirector | CingulateCING | Open-market buy | 23/08/11 | 23/08/14 | 1,823,155 sh | $0.55 | $1,002,735.25 | +187.0% |
CingulateCING | Open-market buy | 23/05/12–23/05/15 | 23/05/16 | 6,000 sh2 trades | $1.06avg. | $6,340 | +17.4% |